HUP0101480A2 - Eljárás koleszterinből nyerhető baktérium-méretű partikulák előállítására - Google Patents
Eljárás koleszterinből nyerhető baktérium-méretű partikulák előállításáraInfo
- Publication number
- HUP0101480A2 HUP0101480A2 HU0101480A HUP0101480A HUP0101480A2 HU P0101480 A2 HUP0101480 A2 HU P0101480A2 HU 0101480 A HU0101480 A HU 0101480A HU P0101480 A HUP0101480 A HU P0101480A HU P0101480 A2 HUP0101480 A2 HU P0101480A2
- Authority
- HU
- Hungary
- Prior art keywords
- cholesterol
- producing particles
- bacterium size
- cholesterol antibody
- bacterium
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
- 239000002245 particle Substances 0.000 title abstract 3
- 235000012000 cholesterol Nutrition 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 title 1
- 230000003627 anti-cholesterol Effects 0.000 abstract 3
- 239000002502 liposome Substances 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000016784 immunoglobulin production Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000010253 intravenous injection Methods 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A találmány tárgya olyan eljárás melynek segítségével nagy tisztaságúkoleszterinből mikrokokkusz méretű liposoma partikulák állíthatók elő,amelyek alkalmasak intravenás injekció formájában aktív immunizálássalantikoleszterin antitesttermelés kiváltására és az antikoleszterinantitesthiány vagy antikoleszterin antitesttiter-csökkenéskövetkeztében kialakuló betegségek gyógyítására. A liposoma partikulaszuszpenzió intravenás beadása esetén a stabilizáló szerepet önmagábanismert adalékanyagok, és izotóniás körülményeket biztosítósegédanyagok biztosítják. Ó
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0101480A HUP0101480A2 (hu) | 2001-04-11 | 2001-04-11 | Eljárás koleszterinből nyerhető baktérium-méretű partikulák előállítására |
| PCT/HU2002/000029 WO2002083100A1 (en) | 2001-04-11 | 2002-04-10 | Liposomes consisting mainly of cholesterol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0101480A HUP0101480A2 (hu) | 2001-04-11 | 2001-04-11 | Eljárás koleszterinből nyerhető baktérium-méretű partikulák előállítására |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU0101480D0 HU0101480D0 (en) | 2001-06-28 |
| HUP0101480A2 true HUP0101480A2 (hu) | 2004-01-28 |
Family
ID=89979198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101480A HUP0101480A2 (hu) | 2001-04-11 | 2001-04-11 | Eljárás koleszterinből nyerhető baktérium-méretű partikulák előállítására |
Country Status (2)
| Country | Link |
|---|---|
| HU (1) | HUP0101480A2 (hu) |
| WO (1) | WO2002083100A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0204064A2 (hu) * | 2002-11-26 | 2005-07-28 | István Horváth | Eljárás koleszterinből nyerhető baktérium méretű partikulák előállítására, valamint az eljárással előállított partikula |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043107A (en) * | 1986-08-21 | 1991-08-27 | Vestar Research, Inc. | Preparation small unilamellar vesicles including polyene antifungal antibiotics |
| US6214388B1 (en) * | 1994-11-09 | 2001-04-10 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
-
2001
- 2001-04-11 HU HU0101480A patent/HUP0101480A2/hu unknown
-
2002
- 2002-04-10 WO PCT/HU2002/000029 patent/WO2002083100A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002083100A1 (en) | 2002-10-24 |
| HU0101480D0 (en) | 2001-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017265011B2 (en) | Methods of administering high concentrations of nitric oxide | |
| PH12016500004A1 (en) | Pcsk9 vaccine | |
| TNSN05180A1 (en) | Liquid pharmaceutical formulations of palonosetron | |
| TWI256891B (en) | 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations | |
| WO2005063820A3 (en) | Il-7 fusion proteins | |
| NZ628328A (en) | Rna formulation for immunotherapy | |
| MX2007003171A (es) | Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico. | |
| WO2015043613A8 (en) | Particles comprising a shell with rna | |
| WO2008024303A3 (en) | Compounds for treating proliferative disorders | |
| ATE512115T1 (de) | Monodisperse nanokristalle mit kern/schale und anderen komplexen strukturen sowie herstellungsverfahren dafür | |
| MY147449A (en) | 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders | |
| HUP0303720A2 (hu) | Egy immunstimuláns oligonukleotidot és egy tokolt tartalmazó adjuvánskészítmény | |
| EP1077719A4 (en) | VACCINE DELIVERY SYSTEM | |
| BR112014009305A2 (pt) | lipossomas liofilizadas | |
| MX2019000547A (es) | Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas. | |
| MXPA02010565A (es) | Produccion de policetidos. | |
| PH12015501705A1 (en) | Methods for producing diketopiperazines and compositions containing diketopiperazines | |
| WO2006027300A3 (en) | Carrier conjugates of gnrh-peptides | |
| MX2007004799A (es) | Proceso para la produccion de maltodextrinas y maltodextrinas. | |
| WO2003017032A3 (en) | Computer-based methods of designing molecules | |
| WO2023031392A3 (en) | Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine | |
| TW200513551A (en) | Process for preparing a stabilized ideal oxygen precipitating silicon wafer | |
| HUP0101480A2 (hu) | Eljárás koleszterinből nyerhető baktérium-méretű partikulák előállítására | |
| MY143936A (en) | Process for preparing crystalline ciclesonide with defined particle size | |
| HUP0203756A2 (en) | Ciclesonide-containing aqueous pharmaceutical composition |